Overview

Study to Investigate the Effect of AB-101 in Breast Cancer Survivors

Status:
Completed
Trial end date:
2019-10-12
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to investigate the possibility that a topical drug could restore nipple sensitivity and improve sexual quality of life in breast cancer survivors.
Phase:
Early Phase 1
Details
Lead Sponsor:
Applied Biology, Inc.
Treatments:
Phenylephrine